|
US4708934A
(en)
|
1984-09-27 |
1987-11-24 |
Unigene Laboratories, Inc. |
α-amidation enzyme
|
|
US6319685B1
(en)
|
1984-09-27 |
2001-11-20 |
Unigene Laboratories, Inc. |
Alpha-amidating enzyme compositions and processes for their production and use
|
|
US5789234A
(en)
|
1987-08-14 |
1998-08-04 |
Unigene Laboratories, Inc. |
Expression systems for amidating enzyme
|
|
US5102666A
(en)
|
1990-09-11 |
1992-04-07 |
Oramed, Inc. |
Calcium polycarbophil controlled release composition and method
|
|
US5359030A
(en)
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
US6692766B1
(en)
|
1994-06-15 |
2004-02-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Controlled release oral drug delivery system
|
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
US5912014A
(en)
|
1996-03-15 |
1999-06-15 |
Unigene Laboratories, Inc. |
Oral salmon calcitonin pharmaceutical products
|
|
US5773647A
(en)
|
1997-02-07 |
1998-06-30 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
AU742270B2
(en)
|
1997-04-16 |
2001-12-20 |
Enteris Biopharma, Inc. |
Direct expression of peptides into culture media
|
|
JP2002531518A
(ja)
|
1998-12-04 |
2002-09-24 |
プロヴァリス・ユーケー・リミテッド |
インスリン含有医薬組成物
|
|
NZ534409A
(en)
|
1999-04-05 |
2006-03-31 |
Emisphere Tech Inc |
Disodium salts, monohydrates, and ethanol solvates for delivering active agents
|
|
US6780846B1
(en)
|
1999-09-27 |
2004-08-24 |
Elan Corporation, Plc |
Membrane translocating peptide drug delivery system
|
|
GB2368792A
(en)
|
2000-10-06 |
2002-05-15 |
Roger Randal Charles New |
Absorption enhancers
|
|
US6673574B2
(en)
|
2000-11-30 |
2004-01-06 |
Unigene Laboratories Inc. |
Oral delivery of peptides using enzyme-cleavable membrane translocators
|
|
US7316819B2
(en)
|
2001-03-08 |
2008-01-08 |
Unigene Laboratories, Inc. |
Oral peptide pharmaceutical dosage form and method of production
|
|
US6713452B2
(en)
*
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
|
EP1608347B1
(en)
|
2003-03-28 |
2014-08-13 |
Sigmoid Pharma Limited |
Solid oral dosage form containing seamless microcapsules
|
|
GB0308732D0
(en)
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Absorption enhancers
|
|
JP4829783B2
(ja)
*
|
2003-06-24 |
2011-12-07 |
バイオコン・リミテッド |
カルシトニン薬−オリゴマーコンジュゲートの混合物および疼痛治療における使用方法
|
|
PT2316473E
(pt)
|
2003-07-23 |
2013-09-20 |
Novartis Ag |
Utilização de calcitonina na osteoartrite
|
|
AU2004317954A1
(en)
|
2003-09-17 |
2005-10-13 |
Chiasma, Inc. |
Compositions capable of facilitating penetration across a biological barrier
|
|
JP2008506750A
(ja)
|
2004-07-22 |
2008-03-06 |
ティオマトリックス・フォルシュンクス・ウント・べラートゥンクス・ゲーエムベーハー |
チオール基を含む化合物の排出ポンプ抑制剤としての使用
|
|
US7445911B2
(en)
|
2004-11-24 |
2008-11-04 |
Unigene Laboratories Inc. |
Enzymatic reactions in the presence of keto acids
|
|
EP1907561B1
(en)
|
2005-06-24 |
2013-08-28 |
Unigene Laboratories, Inc. |
Cell lines for expressing enzyme useful in the preparation of amidated products
|
|
EP2722054B1
(en)
|
2005-09-06 |
2018-03-21 |
Oramed Pharmaceuticals Inc. |
Methods and compositions for oral administration of proteins
|
|
US8093207B2
(en)
|
2005-12-09 |
2012-01-10 |
Unigene Laboratories, Inc. |
Fast-acting oral peptide pharmaceutical products
|
|
PT1834635E
(pt)
|
2006-03-13 |
2011-10-13 |
Advanced In Vitro Cell Technologies S L |
Sistemas estáveis de nanocápsula para a administração de moléculas activas
|
|
BRPI0710503A2
(pt)
|
2006-04-07 |
2011-08-16 |
Merrion Res Iii Ltd |
uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
|
|
US8377863B2
(en)
|
2007-05-29 |
2013-02-19 |
Unigene Laboratories Inc. |
Peptide pharmaceutical for oral delivery
|
|
US8962015B2
(en)
|
2007-09-28 |
2015-02-24 |
Sdg, Inc. |
Orally bioavailable lipid-based constructs
|
|
EP2405934B1
(en)
*
|
2009-03-12 |
2014-03-26 |
Nordic Bioscience A/S |
Treatment of diabetes and metabolic syndrome
|
|
WO2011051312A1
(en)
*
|
2009-10-30 |
2011-05-05 |
Novo Nordisk A/S |
Derivatives of cgrp
|
|
JP6231386B2
(ja)
*
|
2010-11-09 |
2017-11-15 |
ノヴォ ノルディスク アー/エス |
リンカーを有する二重アシル化されたglp−1誘導体
|
|
SI3095484T1
(en)
*
|
2011-11-02 |
2018-08-31 |
Keybioscience Ag |
Calcitonin mimetics for the treatment of diseases and disorders
|
|
US9533022B2
(en)
*
|
2011-11-02 |
2017-01-03 |
KeyBioscience A/S |
Peptide analogs for treating diseases and disorders
|
|
CA2854175A1
(en)
*
|
2011-11-02 |
2013-05-10 |
Keybioscience Ag |
Peptide analogs for treating diseases and disorders
|
|
BR112016010643A2
(pt)
*
|
2013-11-14 |
2017-12-05 |
Keybioscience Ag |
peptídeo
|
|
GB201500263D0
(en)
*
|
2015-01-08 |
2015-02-25 |
Keybioscience Ag |
Calcitonin analogues for treating diseases and disorders
|
|
EP3359181A1
(en)
*
|
2015-10-07 |
2018-08-15 |
Cyprumed GmbH |
Pharmaceutical formulations for the oral delivery of peptide drugs
|
|
KR102444366B1
(ko)
*
|
2016-06-03 |
2022-09-19 |
케모센트릭스, 인크. |
간 섬유화 치료 방법
|